Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group
Authors
Sclafani, F.Fontana, E.
Wyrwicz, L.
Wagner, A. D.
Valle, Juan W
Smyth, E.
Peeters, M.
Obermannova, R.
Neuzillet, C.
Lutz, M. P.
Koessler, T.
Ben-Aharon, I.
Arnold, D.
Alsina, M.
Moehler, M.
Affiliation
Department of Medical Oncology, Institut Jules Bordet, Rue Meylemeersch 90, Anderlecht 1070, Belgium; Université Libre de Bruxelles (ULB), Brussels, Belgium; European Organisation for Research and Treatment of Cancer, Brussel, BelgiumIssue Date
2022
Metadata
Show full item recordAbstract
Recently, we have witnessed impressive diagnostic and therapeutic changes for gastrointestinal cancer patients. New challenges brought by the COVID-19 pandemic have led us to re-evaluate our work priorities. Thanks to the commendable resilience of both investigators and patients, however, clinical research never stopped. In addition to conducting cutting-edge research and serving patients' needs, as EORTC Gastrointestinal Tract Cancer Group, we are committed to pursuing educational initiatives beneficial to the entire European oncology community and beyond. In this regard, we have been providing critical discussions of new data from major international meetings. In this article, we discuss results of important selected studies presented at the 2022 ASCO Gastrointestinal Cancer Symposium, putting them in perspectives and highlighting potential implications for routine practice. With the number of in-person attendees and practice-changing/informing trials presented, this meeting represented a milestone in the return to normality as well as in the fight against cancer.Citation
Sclafani F, Fontana E, Wyrwicz L, Wagner AD, Valle JW, Smyth E, et al. Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group. Clinical Colorectal Cancer. Elsevier BV; 2022.Journal
Clinical Colorectal CancerDOI
10.1016/j.clcc.2022.04.001PubMed ID
35637095Additional Links
https://dx.doi.org/10.1016/j.clcc.2022.04.001Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.clcc.2022.04.001
Scopus Count
Collections
Related articles
- Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group.
- Authors: Koessler T, Alsina M, Arnold D, Ben-Aharon I, Lutz MP, Obermannova R, Peeters M, Sclafani F, Smyth E, Valle JW, Wagner AD, Wyrwicz L, Fontana E, Moehler M
- Issue date: 2021 Sep
- ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group's perspective.
- Authors: Koessler T, Alsina M, Arnold D, Ben-Aharon I, Collienne M, Lutz MP, Neuzillet C, Obermannova R, Peeters M, Sclafani F, Smyth E, Valle JW, Wagner AD, Wyrwicz L, Fontana E, Moehler M
- Issue date: 2022 Apr
- Self-Reported COVID-19 Infections and Social Mixing Behavior at Oncology Meetings.
- Authors: Talcott WJ, Chen K, Peters GW, Reddy KK, Weintraub SM, Mougalian SS, Adelson K, Evans SB
- Issue date: 2022 May 19
- Precision medicine for gastrointestinal cancers: a conference report.
- Authors: Sahin IH
- Issue date: 2020 May 27
- Translational challenges from the 2014 Gastrointestinal Cancers Symposium: toward a true tailored therapy through effective research.
- Authors: Aprile G, Giuliani F, Cordio S, Sartore-Bianchi A, Bencardino K, Ongaro E, Martines C, Giampieri R, Bordonaro R, Siena S, Cascinu S, Scartozzi M
- Issue date: 2014 May